Clinical Trial Update: Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia [Phase 1, Phase 2]

View source ↗

Summary

The document reports that Phase 1 and Phase 2 studies of ITI-007 (lumateperone) in healthy elderly volunteers and elderly patients with Alzheimer's disease have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Caplyta (lumateperone) (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED